(Q51580738)

7 April 2018

title

Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study. (English)

1 reference

7 April 2018

0 references

1 reference

1 reference

Daubresse JC

1

1 reference

7 April 2018

Kolanowski J

2

1 reference

7 April 2018

Krzentowski G

3

1 reference

7 April 2018

Kutnowski M

4

1 reference

7 April 2018

Scheen A

5

1 reference

7 April 2018

Van Gaal L

6

1 reference

7 April 2018

publication date

1 July 1996

1 reference

7 April 2018

published in

Obesity

1 reference

7 April 2018

volume

4

1 reference

7 April 2018

issue

4

1 reference

7 April 2018

page(s)

391-396

1 reference

7 April 2018

Metformin revisited: its actions and indications for use.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

21 January 2018

The problem of obesity

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Fluoxetine, a selective inhibitor of serotonin uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Fenfluramine increases insulin action in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

The results of treatment for obesity: a review of the literature and report of a series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

Very Low Calorie Diets: Their Efficacy, Safety, and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1996.TB00247.X

10.1002/J.1550-8528.1996.TB00247.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018